Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

41. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. (Abstract)

Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea, and a reduction in lung function, quality of life, and life expectancy. Apart from smoking cessation, no other treatments that slow lung function decline are available. Roflumilast and cilomilast are oral phosphodiesterase-4 (PDE₄) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD (...) in the analyses for roflumilast (28 trials with 18,046 participants) or cilomilast (14 trials with 6457 participants) or tetomilast (1 trial with 84 participants), with a duration between six weeks and one year or longer. These trials included people across international study centres with moderate to very severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades II to IV), with mean age of 64 years. We judged risks of selection bias, performance bias, and attrition bias as low overall

2020 Cochrane

42. Clinical Relevance of Sarcopenia in Individuals with COPD: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

IN PULMONARY REHABILITATION > > > Clinical Relevance of Sarcopenia in Individuals with COPD: A Systematic Review and Meta-Analysis Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A7382 Clinical Relevance of Sarcopenia in Individuals with COPD: A Systematic Review and Meta-Analysis x V.S. Probst , x W. Sepúlveda-Loyola , x C. Osadnik , x S. Phu , x A.A. Morita , x C.C.R. Galvan , x J.M. Felcar , x G. Duque , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services (...) Clinical Relevance of Sarcopenia in Individuals with COPD: A Systematic Review and Meta-Analysis Clinical Relevance of Sarcopenia in Individuals with COPD: A Systematic Review and Meta-Analysis | D68. CLINICAL CHARACTERISTICS AND RISK STRATIFICATION IN PULMONARY REHABILITATION Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: D68. CLINICAL CHARACTERISTICS AND RISK STRATIFICATION

2020 D68. CLINICAL CHARACTERISTICS AND RISK STRATIFICATION IN PULMONARY REHABILITATION

43. Red Cell Distribution Width as a Marker for Pulmonary Hypertension in COPD: A Systematic Review Full Text available with Trip Pro

Red Cell Distribution Width as a Marker for Pulmonary Hypertension in COPD: A Systematic Review Red Cell Distribution Width as a Marker for Pulmonary Hypertension in COPD: A Systematic Review | B58. BIOMARKERS AND IMAGING IN PULMONARY VASCULAR DISEASE: CLINICAL Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: B58. BIOMARKERS AND IMAGING IN PULMONARY VASCULAR DISEASE: CLINICAL > > > Red (...) Cell Distribution Width as a Marker for Pulmonary Hypertension in COPD: A Systematic Review Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A3863 Red Cell Distribution Width as a Marker for Pulmonary Hypertension in COPD: A Systematic Review x D. Ravi , x N. Sharma , x P.O. Ochieng , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services General Information Copyright © 1987-2020 American Thoracic Society, All Rights Reserved.

2020 B58. BIOMARKERS AND IMAGING IN PULMONARY VASCULAR DISEASE: CLINICAL

44. Effectiveness of Telehealth-Based Interventions with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

Effectiveness of Telehealth-Based Interventions with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Effectiveness of Telehealth-Based Interventions with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis | B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: B103. TREATMENT OF OBSTRUCTIVE LUNG (...) DISEASE > > > Effectiveness of Telehealth-Based Interventions with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A4308 Effectiveness of Telehealth-Based Interventions with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis x S.M. Alghamdi , x J.S. Alqahtani , x A.M. Aldhahir , x A.M. Alrajeh , x Y.S. Aldabayan , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals

2020 B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE

45. Prediction Models for Exacerbations of COPD: A Qualitative Systematic Review and Critical Appraisal Full Text available with Trip Pro

Prediction Models for Exacerbations of COPD: A Qualitative Systematic Review and Critical Appraisal Prediction Models for Exacerbations of COPD: A Qualitative Systematic Review and Critical Appraisal | C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD (...) > > > Prediction Models for Exacerbations of COPD: A Qualitative Systematic Review and Critical Appraisal Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A4810 Prediction Models for Exacerbations of COPD: A Qualitative Systematic Review and Critical Appraisal x S. Shuyuan , x Z. qingxin , x S. feng , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services General Information Copyright © 1987-2020 American Thoracic Society, All Rights Reserved.

2020 C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD

46. The Use of Devices for Airway Clearance in Patients with Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis Full Text available with Trip Pro

in: C55. MUSCLES, LUNGS, AND HEART: UNLOCKING EXERCISE IN PULMONARY REHABILITATION > > > The Use of Devices for Airway Clearance in Patients with Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A5506 The Use of Devices for Airway Clearance in Patients with Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis x E. Daynes , x A.W. Jones , x N.J. Greening , x S.J. Singh , 25 (...) The Use of Devices for Airway Clearance in Patients with Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis The Use of Devices for Airway Clearance in Patients with Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis | C55. MUSCLES, LUNGS, AND HEART: UNLOCKING EXERCISE IN PULMONARY REHABILITATION Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search

2020 C55. MUSCLES, LUNGS, AND HEART: UNLOCKING EXERCISE IN PULMONARY REHABILITATION

47. A Systematic Review and Meta-Analysis on the Effectiveness of Community-Based Non-Pharmacological Interventions to Improve the Health Outcomes Among People with Chronic Obstructive Pulmonary Disease (COPD) Full Text available with Trip Pro

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES > > > A Systematic Review and Meta-Analysis on the Effectiveness of Community-Based Non-Pharmacological Interventions to Improve the Health Outcomes Among People with Chronic Obstructive Pulmonary Disease (COPD) Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A2201 A Systematic (...) A Systematic Review and Meta-Analysis on the Effectiveness of Community-Based Non-Pharmacological Interventions to Improve the Health Outcomes Among People with Chronic Obstructive Pulmonary Disease (COPD) A Systematic Review and Meta-Analysis on the Effectiveness of Community-Based Non-Pharmacological Interventions to Improve the Health Outcomes Among People with Chronic Obstructive Pulmonary Disease (COPD) | A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES Cookies Notification

2020 A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES

48. Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review Full Text available with Trip Pro

of Respiratory and Critical Care Medicine 2020;201:A3374 Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review x A.W. Wong , x J. Liang , x V. Cottin , x C.J. Ryerson , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services General Information Copyright © 1987-2020 American Thoracic Society, All Rights Reserved. (...) Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review | B42. ILD EPIDEMIOLOGY I Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: B42. ILD EPIDEMIOLOGY I > > > Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review Abstract American Journal

2020 B42. ILD EPIDEMIOLOGY I

49. Prediction Models for the Development of COPD: A Qualitative Systematic Review and Critical Appraisal Full Text available with Trip Pro

Prediction Models for the Development of COPD: A Qualitative Systematic Review and Critical Appraisal Prediction Models for the Development of COPD: A Qualitative Systematic Review and Critical Appraisal | C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD (...) > > > Prediction Models for the Development of COPD: A Qualitative Systematic Review and Critical Appraisal Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A4818 Prediction Models for the Development of COPD: A Qualitative Systematic Review and Critical Appraisal x Q.X. Zhou , x S.Y. Shi , x F. Sun , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services General Information Copyright © 1987-2020 American Thoracic Society, All Rights Reserved.

2020 C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD

50. Pulmonary Rehabilitation for Indigenous Adults with Chronic Obstructive Pulmonary Disease in Australia, Canada, New Zealand and the United States of America: A Systematic Review Full Text available with Trip Pro

you are agreeing to our use of cookies. Search Menu Connect With Us Search in: A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES > > > Pulmonary Rehabilitation for Indigenous Adults with Chronic Obstructive Pulmonary Disease in Australia, Canada, New Zealand and the United States of America: A Systematic Review Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A2197 Pulmonary Rehabilitation for Indigenous Adults with Chronic Obstructive Pulmonary Disease (...) Pulmonary Rehabilitation for Indigenous Adults with Chronic Obstructive Pulmonary Disease in Australia, Canada, New Zealand and the United States of America: A Systematic Review Pulmonary Rehabilitation for Indigenous Adults with Chronic Obstructive Pulmonary Disease in Australia, Canada, New Zealand and the United States of America: A Systematic Review | A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES Cookies Notification This site uses cookies. By continuing to browse the site

2020 A61. KEYS TO THE DELIVERY OF PULMONARY REHABILITATION SERVICES

51. The Effect of Smoking Cessation Program for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

in: C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD > > > The Effect of Smoking Cessation Program for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A4833 The Effect of Smoking Cessation Program for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis x H. Joo , x Y. Kim , x K.H. Yoo , x C.K. Rhee , 25 Broadway New York, NY (...) The Effect of Smoking Cessation Program for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis The Effect of Smoking Cessation Program for Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis | C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search

2020 C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD

52. The Association Between Serum Bilirubin and Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Systematic Review Full Text available with Trip Pro

and Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Systematic Review Abstract American Journal of Respiratory and Critical Care Medicine 2020;201:A2861 The Association Between Serum Bilirubin and Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Systematic Review x D. MacDonald , x K.M. Kunisaki , x A.K. Baldomero , 25 Broadway New York, NY 10004 (212) 315-8600 ATS Journals Services General Information Copyright © 1987-2020 American Thoracic Society, All Rights Reserved. (...) The Association Between Serum Bilirubin and Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Systematic Review The Association Between Serum Bilirubin and Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Systematic Review | B24. BIOMARKERS IN COPD Cookies Notification This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Search Menu Connect With Us Search in: B24. BIOMARKERS IN COPD > > > The Association Between Serum Bilirubin

2020 B24. BIOMARKERS IN COPD

53. Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD). (Abstract)

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD). Escalating awareness of the magnitude of the challenge posed by low levels of physical activity in people with chronic obstructive pulmonary disease (COPD) highlights the need for interventions to increase physical activity participation. The widely-accepted benefits of physical activity, coupled with the increasing availability of wearable monitoring devices to objectively measure (...) participation, has led to a dramatic rise in the number and variety of studies that aimed to improve the physical activity of people with COPD. However, little was known about the relative efficacy of interventions tested so far.In people with COPD, which interventions are effective at improving objectively-assessed physical activity?We identified trials from the Cochrane Airways Trials Register Register, which contains records identified from bibliographic databases including the Cochrane Central Register

2020 Cochrane

54. Chronic obstructive pulmonary disease (COPD)

, is a major public health problem that is both preventable and treatable. COPD is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and lungs to noxious articles or gases. Exacerbations and comorbidities contribute to overall severity in individual patients. Recommendations for the diagnosis and treatment of patients with concurrent COPD and asthma are excluded from this guideline because these patients (...) . In addition to identifying the recently published guidelines that meet the above standards, a literature search was conducted to identify studies relevant to the key questions that are not addressed by the external guidelines. External guidelines eligible for adapting ? 2019 Update of 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management and prevention of COPD ? 2018 KP National Clinical Practice Guideline: Chronic Obstructive Pulmonary Disease

2020 Kaiser Permanente Clinical Guidelines

55. Relationship between dietary patterns and COPD: a systematic review and meta-analysis Full Text available with Trip Pro

, Stevens J , Heiss G , et al. Dietary fiber, lung function, and chronic obstructive pulmonary disease in the atherosclerosis risk in communities study . Yang L , Lu X , Deng J , et al. Risk factors shared by COPD and lung cancer and mediation effect of COPD: two center case–control studies . Brigham EP , Steffen LM , London SJ . Diet pattern and respiratory morbidity in the Atherosclerosis Risk in Communities Study . . Steinemann N , Grize L , Pons M . Associations between dietary patterns and post (...) with chronic obstructive airway diseases . Hanson C , Rutten EP , Wouters EFM , et al. Influence of diet and obesity on COPD development and outcomes . Lamprecht B , McBurnie MA , Vollmer WM , et al. COPD in never smokers: RESULTS from the population-based burden of obstructive lung disease study . Kaluza J , Larsson SC , Orsini N , et al. Fruit and vegetable consumption and risk of COPD: a prospective cohort study of men . Hu FB . Dietary pattern analysis: a new direction in nutritional epidemiology

2020 ERJ open research

57. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review Full Text available with Trip Pro

of TCM Cheng-xiang Wang Beijing University of TCM Mei Han Beijing University of TCM Corresponding Author DOI: License: This work is licensed under a CC BY 4.0 License. View the published version . Abstract Objective: To investigate the clinical characteristics between the frequent exacerbator with chronic bronchitis (FE-CB) phenotype and the non-exacerbator (NE) phenotype among patients with chronic obstructive pulmonary disease (COPD). Methods: We searched CNKI, Wan fang, Chongqing VIP, China (...) the published version . Abstract Objective: To investigate the clinical characteristics between the frequent exacerbator with chronic bronchitis (FE-CB) phenotype and the non-exacerbator (NE) phenotype among patients with chronic obstructive pulmonary disease (COPD). Methods: We searched CNKI, Wan fang, Chongqing VIP, China Biology Medicine disc, PubMed, Cochrane Library, and EMBASE databases for relevant studies published as of April 30, 2019. All studies that investigated COPD patients with the FE-CB

2020 Research Square

58. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis Full Text available with Trip Pro

caused by COVID-19 in patients with chronic obstructive pulmonary disease (COPD), and we update information in smokers. Methods We systematically searched electronic databases from inception to March 24, 2020. Data were extracted by two independent authors in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Study quality was assessed using a modified version of the Newcastle-Ottawa Scale. We synthesised a narrative from eligible studies and conducted (...) London , London, UK 4 Respiratory Care Department, Faculty of Applied Medical Sciences, Jazan University , Jazan, Saudi Arabia Saeed M. Alghamdi 5 National Heart and Lung Institute, Imperial College London , London, UK 6 Faculty of Applied Medical Sciences, Umm Al-Qura University , Makkah, Saudi Arabia Mater Almehmadi 7 UCL Institute for Risk and Disaster , London, UK Abdullah S Alqahtani 2 Department of Respiratory Care, Prince Sultan Military College of Health Sciences , Dammam, Saudi Arabia

2020 Cold Spring Harbor Laboratory

59. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review Full Text available with Trip Pro

of TCM Cheng-xiang Wang Beijing University of TCM Mei Han Beijing University of Traditional Chinese Medicine Corresponding Author DOI: License: This work is licensed under a CC BY 4.0 License. View the published version . Abstract Objective: To investigate the clinical characteristics between the frequent exacerbator with chronic bronchitis (FE-CB) phenotype and the non-exacerbator (NE) phenotype among patients with chronic obstructive pulmonary disease (COPD). Methods: We searched CNKI, Wan fang (...) the frequent exacerbator with chronic bronchitis (FE-CB) phenotype and the non-exacerbator (NE) phenotype among patients with chronic obstructive pulmonary disease (COPD). Methods: We searched CNKI, Wan fang, Chongqing VIP, China Biology Medicine disc, PubMed, Cochrane Library, and EMBASE databases for relevant studies published as of April 30, 2019. All studies that investigated COPD patients with the FE-CB and NE phenotypes and which qualified the inclusion criteria were included. Cross-Sectional

2020 Research Square

60. Purified human alpha1-proteinase inhibitor (A1-PI) for the treatment of alpha1-proteinase inhibitor deficiency, leading to chronic obstructive pulmonary disease (COPD)

Purified human alpha1-proteinase inhibitor (A1-PI) for the treatment of alpha1-proteinase inhibitor deficiency, leading to chronic obstructive pulmonary disease (COPD) 1 Public Summary Document Application No. 1530 – Purified human alpha1-proteinase inhibitor for the treatment of alpha1-proteinase inhibitor deficiency, leading to chronic obstructive pulmonary disease Applicant: National Blood Authority (NBA) Date of MSAC consideration: MSAC 74th Meeting, 22-23 November 2018 Context for decision (...) : MSAC makes its advice in accordance with its Terms of Reference, visit the MSAC website 1. Purpose of application An application requesting National Product List (NPL) blood product listing of purified human alpha1-proteinase inhibitor (A1-PI) for the treatment of A1-PI deficiency, leading to chronic obstructive pulmonary disease (COPD), was received from the National Blood Authority (NBA) by the Department of Health. 2. MSAC’s advice to the Minister After considering the strength of available

2020 Medical Services Advisory Committee